Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
26.44
+0.19 (0.72%)
Aug 10, 2026, 3:14 PM EDT - Market open
Dyne Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $40 | Buy | Maintains | $40 | +51.29% | Aug 5, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 31, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $37 | Buy | Maintains | $37 | +39.94% | Jul 31, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $30 → $35 | Buy | Reiterates | $30 → $35 | +32.38% | Jul 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $47 | Buy | Reiterates | $47 | +77.76% | Jul 30, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $38 | Buy | Maintains | $38 | +43.72% | Jul 30, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $44 | Buy | Reiterates | $44 | +66.41% | Jul 29, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $47 → $45 | Buy | Maintains | $47 → $45 | +70.20% | Jul 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.